UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Epilepsy & behavior, ISSN 1525-5050, 01/2018, Volume 78, pp. 194 - 201
Antiepileptic drug | Alprazolam | Subjective measures | Brivaracetam | Abuse potential | Levetiracetam | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Behavioral Sciences | Science & Technology | Hypnotics and Sedatives - adverse effects | Central Nervous System Depressants - adverse effects | Humans | Middle Aged | Hypnotics and Sedatives - administration & dosage | Anticonvulsants - administration & dosage | Male | Anticonvulsants - pharmacology | Levetiracetam - adverse effects | Central Nervous System Depressants - pharmacology | Pyrrolidinones - administration & dosage | Young Adult | Anticonvulsants - adverse effects | Alprazolam - administration & dosage | Drug-Related Side Effects and Adverse Reactions | Pyrrolidinones - pharmacology | Adult | Female | Alprazolam - pharmacology | Pyrrolidinones - adverse effects | Double-Blind Method | Alprazolam - adverse effects | Levetiracetam - administration & dosage | Street Drugs - adverse effects | Cross-Over Studies | Euphoria | Adolescent | Central Nervous System Depressants - administration & dosage | Levetiracetam - pharmacology | Hypnotics and Sedatives - pharmacology | Drug abuse | Seizures (Medicine) | Analysis | Central nervous system | Index Medicus
Journal Article
Drugs (New York, N.Y.), ISSN 0012-6667, 2008, Volume 68, Issue 17, pp. 2411 - 2417
Insomnia, treatment | Antidepressants, therapeutic use | Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Antidepressive Agents - therapeutic use | Depression - drug therapy | Sleep Initiation and Maintenance Disorders - complications | Humans | Antidepressive Agents - administration & dosage | Depression - complications | Sleep Initiation and Maintenance Disorders - drug therapy | Feasibility Studies
Journal Article
Drug and alcohol dependence, ISSN 0376-8716, 2016, Volume 166, pp. 125 - 133
Psychiatry | Opioid | Concurrent use | Alcohol | Overdose | Polydrug abuse | Benzodiazepine | Life Sciences & Biomedicine | Substance Abuse | Science & Technology | Opioid-Related Disorders - drug therapy | Prospective Studies | Humans | Middle Aged | South Australia - epidemiology | Male | Time Factors | Drug Compounding | Adult | Female | Opiate Substitution Treatment - trends | Retrospective Studies | Prescription Drug Misuse - trends | Alcohol Drinking - prevention & control | Medical Records | Prescription Drug Misuse - prevention & control | Alcohol Drinking - trends | Opioid-Related Disorders - epidemiology | Alcohol Drinking - epidemiology | Analgesics, Opioid - administration & dosage | Central Nervous System Depressants - administration & dosage | Benzodiazepines - administration & dosage | Morphine - administration & dosage | Cohort Studies | New South Wales - epidemiology | Usage | Benzodiazepines | Opioids | Alcoholic beverages | Antianxiety agents | Index Medicus
Journal Article
Neuropsychopharmacology (New York, N.Y.), ISSN 0893-133X, 02/2008, Volume 33, Issue 3, pp. 643 - 652
Alcohol self-administration | Reinforcement | Alcoholism | Dependence | Dynorphin | Opioids | Pharmacology & Pharmacy | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Naltrexone - analogs & derivatives | Rats, Wistar | Central Nervous System Depressants - adverse effects | Injections, Intraventricular | Ethanol - administration & dosage | Male | Naltrexone - pharmacology | Self Administration | Ethanol - blood | Conditioning, Operant - drug effects | Motivation | Ethanol - adverse effects | Alcoholism - physiopathology | Alcoholism - psychology | Naltrexone - administration & dosage | Data Interpretation, Statistical | Receptors, Opioid, mu - drug effects | Administration, Inhalation | Rats | Receptors, Opioid, delta - drug effects | Receptors, Opioid, kappa - drug effects | Animals | Narcotic Antagonists - pharmacology | Central Nervous System Depressants - administration & dosage | Dynorphins - pharmacology | Central Nervous System Depressants - blood | Substance Withdrawal Syndrome - psychology | Index Medicus | dependence | dynorphin | reinforcement | alcoholism | alcohol self-administration | opioids
Journal Article
European journal of pharmacology, ISSN 0014-2999, 2006, Volume 539, Issue 3, pp. 168 - 176
GABA A | Sedation | Flavonoid glycosides | Sleep-enhancing action | Hesperidin | GABA | Biological and medical sciences | Pharmacology. Drug treatments | Medical sciences | Motor Activity - physiology | Rats, Wistar | Plant Extracts | Motor Activity - drug effects | Rats | Male | Glycosides - pharmacology | Central Nervous System Depressants - chemistry | Sleep - drug effects | Central Nervous System Depressants - pharmacology | Dose-Response Relationship, Drug | Animals | Protein Binding - drug effects | Flavonoids - pharmacology | Mice | Sleep - physiology | Flavonoids - chemistry | Glycosides - chemistry | Protein Binding - physiology | Glycosides | Central nervous system | Index Medicus
Journal Article
CNS drugs, ISSN 1172-7047, 07/2013, Volume 27, Issue 7, pp. 531 - 543
Pharmacology & Pharmacy | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Drug Overdose - therapy | Drug Overdose - diagnosis | Humans | Drug-Related Side Effects and Adverse Reactions - etiology | Attention Deficit Disorder with Hyperactivity - drug therapy | Central Nervous System Stimulants - toxicity | Central Nervous System Stimulants - therapeutic use | Central Nervous System Stimulants - pharmacokinetics | Central Nervous System Depressants - therapeutic use | Central Nervous System Depressants - administration & dosage | Drug Overdose - etiology | Central Nervous System Depressants - pharmacokinetics | Central Nervous System Depressants - toxicity | Central Nervous System Stimulants - administration & dosage | Drug-Related Side Effects and Adverse Reactions - diagnosis | Drug-Related Side Effects and Adverse Reactions - therapy | Attention Deficit Disorder with Hyperactivity - epidemiology | Hypertension | Poisons | Cardiac arrhythmia | Plasma | Dopamine | Serotonin | Toxicity | Attention Deficit Hyperactivity Disorder | Blood pressure | Drug therapy | Drug dosages | Index Medicus
Journal Article
Journal of clinical psychopharmacology, ISSN 0271-0749, 11/2015, Volume 35, Issue 6, pp. 672 - 680
overdose | CNS-depressant drugs | neurocognitive recovery | benzodiazepine | opioid | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Outcome Assessment (Health Care) | Cognition Disorders - chemically induced | Humans | Middle Aged | Central Nervous System Depressants - poisoning | Male | Psychomotor Performance - drug effects | Recovery of Function | Central Nervous System Agents - poisoning | Suicide, Attempted | Adult | Female | Drug Overdose - complications | Automobile Driving | Longitudinal Studies | Index Medicus
Journal Article
Pakistan journal of pharmaceutical sciences, ISSN 1011-601X, 03/2019, Volume 32, Issue 2, pp. 563 - 568
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Plant Extracts - chemistry | Plants, Medicinal - chemistry | Plant Extracts - pharmacology | Motor Activity - drug effects | Male | Lethal Dose 50 | Central Nervous System Depressants - chemistry | Sleep - drug effects | Diazepam - pharmacology | Central Nervous System Depressants - pharmacology | Cissus - chemistry | Dose-Response Relationship, Drug | Animals | Behavior, Animal - drug effects | Female | Mice | Drug Evaluation, Preclinical | Methanol - chemistry
Journal Article
Brain, behavior, and immunity, ISSN 0889-1591, 2016, Volume 57, pp. 293 - 303
Psychiatry | Allergy and Immunology | Imipramine | Anxiety-like behavior | Social avoidance | Social defeat | Psychosocial stress | Microglia | Neurosciences | Immunology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Spleen - immunology | Male | Anxiety - prevention & control | Spleen - drug effects | Stress, Psychological - immunology | Imipramine - administration & dosage | Behavior, Animal | Depression - etiology | Depression - metabolism | Inflammation - metabolism | Inflammation - drug therapy | Interleukin-6 - blood | Stress, Psychological - metabolism | Corticosterone - blood | Anxiety - metabolism | Antidepressive Agents, Tricyclic - administration & dosage | Stress, Psychological - drug therapy | Mice, Inbred C57BL | Inflammation - immunology | Inflammation - etiology | Anxiety - immunology | Animals | Depression - prevention & control | Myeloid Progenitor Cells - drug effects | Spleen - metabolism | Antidepressive Agents, Tricyclic - pharmacology | Mice | Imipramine - pharmacology | Anxiety - etiology | Stress, Psychological - complications | Depression - immunology | Inflammation | Corticosterone | Central nervous system | Index Medicus | psychosocial stress | anxiety-like behavior | social avoidance | social defeat | microglia | imipramine
Journal Article